Article | August 8, 2022

Leveraging 505(b)(2): Real-World Evidence Rescues Program

Source: Premier Consulting
FDA Approved

A biotech company could not afford the time and expense of conducting studies recommended by another of its consultants and agreed to by the FDA. Through analysis of the product’s scientific and medical viability, we identified a possible alternative solution. Using our proprietary search methods, our researchers identified key publications to support the 505(b)(2) development plan.

Discover our process in assisting this sponsor in meeting its desired development cost and timeline goals.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader